| Title |
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
|
|---|---|
| Published in |
The Lancet, July 2020
|
| DOI | 10.1016/s0140-6736(20)31605-6 |
| Pubmed ID | |
| Authors |
Feng-Cai Zhu, Xu-Hua Guan, Yu-Hua Li, Jian-Ying Huang, Tao Jiang, Li-Hua Hou, Jing-Xin Li, Bei-Fang Yang, Ling Wang, Wen-Juan Wang, Shi-Po Wu, Zhao Wang, Xiao-Hong Wu, Jun-Jie Xu, Zhe Zhang, Si-Yue Jia, Bu-Sen Wang, Yi Hu, Jing-Jing Liu, Jun Zhang, Xiao-Ai Qian, Qiong Li, Hong-Xing Pan, Hu-Dachuan Jiang, Peng Deng, Jin-Bo Gou, Xue-Wen Wang, Xing-Huan Wang, Wei Chen |
X Demographics
The data shown below were collected from the profiles of 2,699 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Mexico | 423 | 16% |
| United States | 123 | 5% |
| Spain | 73 | 3% |
| Argentina | 59 | 2% |
| United Kingdom | 56 | 2% |
| India | 47 | 2% |
| Japan | 35 | 1% |
| Peru | 34 | 1% |
| Colombia | 29 | 1% |
| Other | 425 | 16% |
| Unknown | 1395 | 52% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2449 | 91% |
| Scientists | 117 | 4% |
| Practitioners (doctors, other healthcare professionals) | 91 | 3% |
| Science communicators (journalists, bloggers, editors) | 42 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 1,635 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1635 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 276 | 17% |
| Researcher | 168 | 10% |
| Student > Master | 137 | 8% |
| Student > Ph. D. Student | 112 | 7% |
| Other | 91 | 6% |
| Other | 293 | 18% |
| Unknown | 558 | 34% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 379 | 23% |
| Biochemistry, Genetics and Molecular Biology | 139 | 9% |
| Immunology and Microbiology | 93 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 69 | 4% |
| Nursing and Health Professions | 65 | 4% |
| Other | 277 | 17% |
| Unknown | 613 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4374. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 March 2024.
All research outputs
#1,049
of 25,818,700 outputs
Outputs from The Lancet
#75
of 43,018 outputs
Outputs of similar age
#70
of 431,603 outputs
Outputs of similar age from The Lancet
#7
of 322 outputs
Altmetric has tracked 25,818,700 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 43,018 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 68.0. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 431,603 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 322 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.